Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-14

Clinical Trial Update: Strategies for Management of Recurrent Pterygium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on strategies for managing recurrent pterygium, sponsored by the University of Nottingham.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nottingham | Conditions: Recurrent Pterygium | Phase 4 | Status: UNKNOWN